Skip to main content

Blog

FDA Approves Generic of Proventil HFA Albuterol Inhaler to Meet Demand Due to COVID-19

The U.S. Food and Drug Administration today approved the first generic of Proventil HFA (albuterol sulfate) Metered Dose Inhaler, 90 mcg/Inhalation, for the treatment or prevention of bronchospasm in patients four years of age and older who have reversible obstructive airway disease, as well as the prevention of exercise-induced bronchospasm in this age group.

Asthma Drug Shortages During COVID-19: A Letter From AAFA’s President and CEO

Because of the COVID-19 (new coronavirus) pandemic, we are facing a challenging and unprecedented time. COVID-19 is a respiratory infection, and the nearly 25 million Americans with asthma are at high risk for complications from the virus. As the leading patient organization for people with asthma and allergies, this has the Asthma and Allergy Foundation of America (AAFA) deeply concerned for your health and well-being.

Emotional Support Animals on Planes: AAFA Submits Comment to the DOT

In January, the U.S. Department of Transportation (DOT) proposed new rules regarding animals on planes . If passed, airlines would no longer be forced to recognize emotional support animals as service animals and may treat them as pets. The Asthma and Allergy Foundation of America (AAFA) has submitted our comment to the DOT on behalf of people with asthma and allergies. Read our comment below. We also encourage you to submit your own comment to the DOT about emotional support animals on...

Alert: FDA Requests Removal of All Ranitidine Products (Zantac) From the Market

The U.S. Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. This is the latest step in an ongoing investigation of a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications (commonly known by the brand name Zantac). The agency has determined that the impurity in some ranitidine products increases over time and when stored at higher than room temperature

Please Don't Stop Your Asthma Medicines – An Editorial From Dr. Mitchell Grayson on the Coronavirus (COVID-19)

With the current spread of the new coronavirus (COVID-19) in the U.S. and around the world, many people with asthma wonder how it would affect them if they got the illness. There is a lot we still don't know about this illness. Dr. Mitchell Grayson, the chair of the Asthma and Allergy Foundation of America's (AAFA) Medical Scientific Council, wrote this article for our blog about what we do know at this time. There have been many questions about how having asthma affects your risk of getting...

Eczema, Hand-Washing and the New Coronavirus (COVID-19): Protecting Yourself and Your Skin

Proper hand-washing is one of the best ways to prevent spreading viruses, like the new coronavirus (COVID-19) and the flu . But when you have a skin condition like eczema (atopic dermatitis or dyshidrotic eczema) , washing your hands often can lead to dry and cracked skin, itchiness, pain and possibly infection. So how can people with eczema protect their skin while protecting themselves from the coronavirus? The Asthma and Allergy Foundation of America (AAFA) asked Dr. Jonathan Silverberg,...

2020 Allergy Capitals™ Report: Seasonal Rankings by City for Spring and Fall

The Asthma and Allergy Foundation of America (AAFA) 2020 Allergy Capitals™ report is now available. This report ranks the top 100 most challenging cities in the continental United States to live in with seasonal allergies. AAFA combines data from both spring and fall to create a ranking of the top 100 cities based on: Pollen counts Allergy medicine use Number of board-certified allergists available The report also includes a breakdown of seasonal rankings of the top cities for both spring...

Generic Montelukast and Singulair Will Now Carry Stronger Warning Label About Possible Side Effects

The U.S. Food and Drug Administration today announced that it is requiring a boxed warning – the agency’s most prominent warning – for montelukast (sold under the brand name Singulair and in generic form) to strengthen an existing warning about the risk of neuropsychiatric events associated with the drug, which is used to treat asthma and allergic rhinitis (hay fever).

Clean Air, Sharp Minds Act Aims to Improve Indoor Air Quality in Schools to Improve Student Health and Learning

On Feb. 27, 2020, Senator Cory Booker and Representative Katherine Clark introduced the Clean Air, Sharp Minds Act. The proposed act would give schools a three-year grant to help them improve indoor air quality (IAQ) . The grant would allow schools in high pollution areas or that pose a severe health and safety threat to install commercial air filters. This program would be managed by the Department of Education and the Environmental Protection Agency (EPA). These grants aim to: Improve the...

Food Allergies – Not Only a Childhood Disease

Researchers estimate the number of people with food allergies in the U.S. to be 32 million. It breaks down to 6 million children and 26 million adults – more than previously thought. 1 It is common for food allergies to develop in childhood, but you can develop a food allergy at any age. Adults are more likely to develop allergies to crustacean shellfish (like crabs, lobster or shrimp), peanuts, milk, tree nuts and fin fish. 1 Adult-onset food allergies are generally life-long and are not...

FDA Approves ProAir HFA Generic, a Quick-Relief Medicine for Asthma

The U.S. Food and Drug Administration today approved the first generic of ProAir HFA (albuterol sulfate) Inhalation Aerosol for the treatment or prevention of bronchospasm in patients four years of age and older with reversible obstructive airway disease and the prevention of exercise-induced bronchospasm in patients four years of age and older.

CERTIFIED Baby Mattress Creates a Healthier Environment for Infants With Asthma and Allergies

Pure Zees recently announced the expansion of its innovative asthma & allergy friendly® mattresses into the U.S. market, unveiling a new U.S. website to help roll out multiple related products through 2020. The Irish-based company has secured coveted certification for their signature infant mattress from both Allergy Standards Limited of Ireland (ASL) and The Asthma and Allergy Foundation of America (AAFA).

February Advocacy Update: Over-the-Counter Medicines, Restaurant Safety and Cleaner Cars

Welcome to your February advocacy update. I’m Jenna Riemenschneider, director of advocacy at the Asthma and Allergy Foundation of America (AAFA). I am pictured above with AAFA board member Renuka Babu Brown and Senator Ed Markey's (D-MA) policy advisor Adam Axler. Over-the-Counter Drug Access and Cleaner Cars Rollbacks AAFA and other members of the Healthy Choices Coalition met with Representative Judy Chu's office. We asked her to co-sponsor the Restoring Access to Medication Act of 2019...

×
×
×
×